Skip to main content
Scientist at the lab)


Driven by Our Patients

Immunology Congress Materials

Congress Materials


Meet Us at an Event

IPIC 2023 8–10 November 2023 Rotterdam, The Netherlands Details

Prescribing information for HAEGARDA® and Berinert® may vary depending on local approval in each country. Therefore, before prescribing HAEGARDA® or Berinert®, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics (SmPC) in your country.

HAEGARDA® and Berinert® are not available in all countries. Consult the CSL Behring Global Products List to see if HAEGARDA® and Berinert® are available in your country.

  1. CSL Ltd Annual Report 2022. CSL Ltd. Published 2022. Accessed September 6, 2022.

May 2023